Treatment of patients with arterial hypertension and metabolic syndrome. The role of the combination drugs

被引：0
|
作者：
Shilov, A. M. [1 ]
Dulaeva, M. S. [1 ]
Osia, A. O. [1 ]
Lishuta, A. S. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2014年 / 10卷 / 01期
关键词：
arterial hypertension; combination therapy; fixed-dose drug combination; enalapril; lercanidipine;
D O I：
10.20996/1819-6446-2014-10-1-92-98
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Data about the current approach to the choice of dual antihypertensive combinations in various clinical situations for treatment of hypertension are presented. Advantages and indications for the combination of an ACE inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from prospective studies on the efficacy and safety of combination of third generation calcium channel blocker lercanidipine with ACE inhibitor enalapril are presented.
引用
收藏
页码：92 / 98
页数：7
相关论文
共 50 条
  • [21] Optimisation of arterial hypertension pharmacotherapy in patients with metabolic syndrome: potential of zofenopril
    Morozova, T. E.
    Andrushchishina, T. B.
    Oshorova, S. D.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2011, (04): : 63 - 68
  • [22] A Rational Approach to the Treatment of Arterial Hypertension in Patients With High Cardiovascular Risk and Metabolic Disorders
    Mamedov, M. N.
    Kovrigina, M. N.
    Toguzova, Z. A.
    KARDIOLOGIYA, 2013, 53 (02) : 85 - 90
  • [23] Pathogenesis of arterial hypertension within the metabolic syndrome
    Ryazanov, AS
    Arakelyants, AA
    Yurenev, AP
    TERAPEVTICHESKII ARKHIV, 2003, 75 (03) : 86 - 88
  • [24] Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment
    Gruenig, Ekkehard
    Ohnesorge, Johanna
    Benjamin, Nicola
    Burhenne, Juergen
    Enderle, Yeliz
    Egenlauf, Benjamin
    Fischer, Christine
    Harutyunova, Satenik
    Huppertz, Andrea
    Klose, Hans
    Haefeli, Walter E.
    RESPIRATION, 2017, 94 (01) : 26 - 37
  • [25] The Role of the Three-Drug Combination Antihypertensive in Improving the Treatment of Arterial Hypertension
    Gilyarevskiy, S. R.
    KARDIOLOGIYA, 2017, 57 (02) : 62 - 67
  • [26] Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
    Medvedev, L. N.
    Kumova, T. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2008, (01): : 40 - 42
  • [27] Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension
    Oleynikov, V. E.
    Gerasimova, A. S.
    Matrosova, I. B.
    Tomashevskaya, Yu. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2007, (04): : 37 - 43
  • [28] Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
    Tishina, E. V.
    Mychka, V. B.
    Zhernakova, Yu. V.
    Ivanov, K. P.
    Tolstov, S. N.
    Chazova, I. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (03): : 40 - 46
  • [29] Influence of antihypertensive drugs on arterial stiffness in patients with arterial hypertension
    Egorkina, N. V.
    Gorbunov, V. M.
    Abirova, E. S.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (05) : 67 - 72
  • [30] Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
    Abasova, L. I.
    Dashdamirov, R. L.
    Bakhshaliev, A. B.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (04): : 107 - 109
12345